Back

Deborah L.V. Keller

Principal, Black Frame Advisors, LLC and Former Chief Executive Officer, Covance Drug Development Director since 2017

Ms. Keller serves as a Principal at Black Frame Advisors, LLC, and is the former CEO of Covance Drug Development—a business segment of Laboratory Corporation of America Holdings. Prior to serving as CEO, Ms. Keller spent more than 28 years at Covance in several leadership roles, including Corporate Executive Vice President and Group President of Research and Development Laboratories, Corporate Senior Vice President and President of Discovery and Translational Services and Vice President of Analytical Services in Europe. She is a trustee of the Wisconsin Alumni Research Foundation (WARF). She previously served on the Board of Directors of of Fishawack Healthcare in addition to her former nonprofit service with WiCell and the Morgridge Institute for Research.

  • Chair of the Nominating and Corporate Governance Committee
  • Member of the Compensation Committee